Prosztatarák: nyitott vizsgálatok itt: Olaszország
117 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozTrial-stage medicine
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Castelfranco Veneto, Milan, Naples, Rome
- Age
- 18 év and over
- People
- 100 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07287150EU 2025-521327-67-00Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Meldola, Milan
- Age
- 18 év and over
- People
- 1310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624EU 2023-504899-25-00Regiszter frissítve: 2026-11-05
3. fázisToborozResearch participation
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
- Where
- Meldola, Verona
- Age
- 18 év and over
- People
- 434 worldwide
- Run by
- ABX advanced biochemical compounds GmbH
See details and how to joinNCT06122584Regiszter frissítve: 2026-11-04
No phaseToborzás még nem indultResearch participation
A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
- Where
- Milan
- Age
- 18 év and over
- People
- 376
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07610083Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Castelfranco Veneto, Foggia, Milan, Naples, Palermo, Rome, Rozzano, Turin
- Age
- 18 év and over
- People
- 1203 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07164443EU 2025-520927-26-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Florence, Frattamaggiore, Milan, Rome, Turin
- Age
- 18 év and over
- People
- 800 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07225946EU 2025-522713-29-00Regiszter frissítve: 2026-11-03
No phaseToborzás még nem indultResearch participation
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
- Where
- Naples
- People
- 50 worldwide
- Run by
- Aristotle University Of Thessaloniki
See details and how to joinNCT07888322Regiszter frissítve: 2026-11-02
3. fázisToborozTrial-stage medicine
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- Where
- Cremona, Meldola, Milan, Naples, Rome, Rozzano, Terni, Trento, Verona
- Age
- 18 év and over
- People
- 900 worldwide
- Run by
- Pfizer
See details and how to joinNCT06629779EU 2024-511652-40-00Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Arezzo, Foggia, Milan, Rome, Rozzano, Siena, Terni, Verona
- Age
- 18 év and over
- People
- 1440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737EU 2024-517423-40-00Regiszter frissítve: 2026-10-30
1/2. fázisToborozTrial-stage medicine
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Rome
- Age
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619EU 2026-525248-13-00Regiszter frissítve: 2026-10-30
1/2. fázisToborozTrial-stage medicine
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Where
- Milan
- Age
- 18 év and over
- People
- 205 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07288359Regiszter frissítve: 2026-10-29
No phaseToborozResearch participation
24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
- Where
- Milan
- Age
- 18 év and over
- People
- 70
- Run by
- IRCCS San Raffaele
See details and how to joinNCT05936736Regiszter frissítve: 2026-10-27
No phaseToborozResearch participation
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
- Where
- Milan
- Age
- 18 év to 95 év
- People
- 2500
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06546267Regiszter frissítve: 2026-10-27
2. fázisToborozTrial-stage medicine
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Bergamo, Genova, Naples, Verona
- Age
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478EU 2023-507641-29-00Regiszter frissítve: 2026-10-26
1. fázisToborozResearch participation
A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
- Where
- Milan
- Age
- 18 év and over
- People
- 26 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-524080-20-00EU 2025-524080-20-00Regiszter frissítve: 2026-10-23
1. fázisToborozTrial-stage medicine
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Where
- Milan
- Age
- 18 év and over
- People
- 208 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07570979Regiszter frissítve: 2026-10-23
2. fázisToborozResearch participation
"APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN".
- Where
- Alba, Arezzo, Bologna, Candiolo, Florence, Foggia, Frattamaggiore, Genoa, Macerata, Misterbianco, Modena, Padova, Parma, Perugia, Reggio Emilia, Rome, Siena, Turin, Udine
- Age
- 18 év and over
- People
- 180
- Run by
- Fondazione Radioterapia Oncologica Onlus
See details and how to join2022-501894-37-00EU 2022-501894-37-00Regiszter frissítve: 2026-10-22
1/2. fázisToborozTrial-stage medicine
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Where
- Milan, Naples, Rome, Rozzano
- Age
- 18 év to 130 év
- People
- 283 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07181161EU 2024-520026-11-00Regiszter frissítve: 2026-10-22
3. fázisToborozTrial-stage medicine
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Where
- Brescia, Ferrara, Genoa, Milan, Negrar, Pisa, Rome, Rozzano
- Age
- 18 év to 100 év
- People
- 450 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05939414EU 2022-502956-29-00Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Catania, Foggia, Meldola, Milan, Terni
- Age
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650EU 2023-504957-11-00Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Foggia, Milan, Modena, Orbassano, Peschiera del Garda, Rozzano, Trento
- Age
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674Regiszter frissítve: 2026-10-20
2. fázisToborzás még nem indultResearch participation
PET-Guided Navigation with Electromagnetic Tracking during PSMA-RadioGuided Surgery: Innovative Bimodal Detection of Nodal Metastases in Prostate Cancer Patients
- Where
- Milan
- Age
- 18 év and over
- People
- 54
- Run by
- Ospedale San Raffaele S.r.l.
See details and how to join2026-526915-12-00EU 2026-526915-12-00Regiszter frissítve: 2026-10-19
No phaseToborozResearch participation
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Age
- 18 év and over
- People
- 1600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779Regiszter frissítve: 2026-10-19
3. fázisToborozTrial-stage medicine
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Milan, Misterbianco, Naples, Negrar, Reggio Emilia, Rozzano
- Age
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110Regiszter frissítve: 2026-10-19
No phaseToborozResearch participation
PSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer
- Where
- Milan
- Age
- 18 év to 85 év
- People
- 12
- Run by
- Niguarda Hospital
See details and how to joinNCT07879820Regiszter frissítve: 2026-10-19
Minden vizsgálat (Prosztatarák) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.